---
title: "Edwards Lifesciences CVP, TAVR Daniel J. Lippis disposes of 619 common shares worth $54,168.69"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298775671.md"
description: "Edwards Lifesciences CVP Daniel J. Lippis exercised employee stock options for 619 shares at $72.68 and immediately sold them at $87.51 on September 11, 2026, totaling $54,168.69. Post-transaction, his direct holdings stand at 40,033 shares, with 3,714 remaining employee stock options."
datetime: "2026-09-11T23:15:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298775671.md)
  - [en](https://longbridge.com/en/news/298775671.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298775671.md)
generator: "portal-rs"
---

# Edwards Lifesciences CVP, TAVR Daniel J. Lippis disposes of 619 common shares worth $54,168.69

-   Edwards Lifesciences CVP, TAVR Daniel J. Lippis exercised employee stock options for 619 shares at $72.68 on Sep. 11, 2026. \* He sold 619 shares at $87.51 on the same day. \* Direct holdings totaled 40,033 shares following the transactions. \* He held 3,714 employee stock options after the exercise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edwards Lifesciences Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001225208-26-007774), on September 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [EW.US](https://longbridge.com/en/quote/EW.US.md)

## Related News & Research

- [Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve](https://longbridge.com/en/news/300805980.md)
- [Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients | EW Stock News](https://longbridge.com/en/news/300725293.md)
- [Edwards Lifesciences CVP TAVR Daniel J. Lippis melepas 619 saham senilai $ 56.966,57](https://longbridge.com/en/news/295581060.md)
- [Danaher Corporation $DHR Stock Sold by CX Institutional](https://longbridge.com/en/news/300849281.md)
- [Edwards Lifesciences Comments on TAVR National Coverage Decision | EW Stock News](https://longbridge.com/en/news/298649035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**